Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1061-1070 of 2869 for cancer

Edit search filters
  1. A Study Of Tyrosine Kinase Inhibitor ICP-022 In Patients With R/r B-Cell Malignancies

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. A Study To Evaluate Pembrolizumab Combined With Intensive Chemotherapy To Treat Patients With Acute Myeloid Leukemia

    Jacksonville, FL

  3. AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL

    Rochester, MN

  4. A Study To Evaluate EAA181 To Treat Newly-diagnosed Multiple Myeloma

    La Crosse, WI, Rochester, MN

  5. Phase 1 Study To Investigate TCRTs KRAS Mutation In Unresectable, Advanced, And/or Metastatic Solid Tumors

    Jacksonville, FL

  6. Amino Acid Pet For Brain Tumors

    Rochester, MN

  7. Stereotactic Body Radiotherapy (SBRT) Versus Sublobar Resection for High-Risk Patients with Early Stage Non-Small Lung Cancer (NSCLC)

    Rochester, MN

  8. A Study Combining Tofacitinib with Gemcitabine for the Treatment of Pancreas Cancer in Patients who are Losing Weight

    Rochester, MN

  9. A Study To Evaluate Durvalumab Alone Or In Combination With Novel Agents In Subjects With NSCLC

    Scottsdale/Phoenix, AZ

  10. A Study Of Prehabilitation In Patients With Multiple Myeloma Receiving CAR-T Therapy

    Rochester, MN

.

Mayo Clinic Footer